You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.
Patients and Visitors Learn About Clinical Trials Find a Clinical Trial Cancer

Cancer Trials

We offer a number of clinical trials for cancer. Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.

Page 1 of 5 | Results 1 - 10 of 46

D14122 Phase II study of Pre-emptive OsciLLation of ER activitY levels through alternation of estradiol/anti-estrogen therapies prior to disease progression in ER+/HER2- metastatic breast cancer (POLLY)

Grace Makari-Judson, MD
Cancer - Breast, Cancer

D'Amour Center for Cancer Care

3350 Main Street
Springfield, MA 01199

A Home Based Study to Enhance Activity in Breast Cancer Survivors

Grace Makari-Judson, MD
Cancer, Cancer - Breast

D'Amour Center for Cancer Care

3350 Main Street
Springfield, MA 01199

A PHASE II EVALUATION OF COPANLISIB (BAY 80-6946) (IND #130822), A SELECTIVE INHIBITOR OF PI3KCA, IN PATIENTS WITH PERSISTENT OR RECURRENT ENDOMETRIAL CARCINOMA HARBORING PIK3CA HOTSPOT MUTATIONS

James Hoffman, MD
Cancer, Cancer-Gynecologic

D'Amour Center for Cancer Care

3350 Main Street
Springfield, MA 01199

A PHASE III, MULTICENTER, RANDOMIZED, STUDY OF ATEZOLIZUMAB VERSUS PLACEBO ADMINISTERED IN COMBINATION WITH PACLITAXEL, CARBOPLATIN, AND BEVACIZUMAB TO PATIENTS WITH NEWLY-DIAGNOSED STAGE III OR STAGE IV OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER (GOG 3015)

James Hoffman, MD
Cancer-Gynecologic, Cancer

D'Amour Center for Cancer Care

3350 Main Street
Springfield, MA 01199

A Phase II Study of Talazoparib (BMN 673) in Patients with Homologous Recombination Repair Deficiency Positive Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)

John McCann, MD
Cancer, Cancer - Lung

D'Amour Center for Cancer Care

3350 Main Street
Springfield, MA 01199

A Phase II Trial Evaluating Cisplatin (NSC #119875) And Gemcitabine (NSC # 613327) Concurrent With Intensity-Modulated Radiation Therapy (IMRT) In The Treatment Of Locally Advanced Squamous Cell Carcinoma Of The Vulva

The purpose of this study is to find out if radiation therapy along with the addition of the drugs, cisplatin and gemcitabine, works and to find out what side effects or surgical complications are caused by treatment with this combination.
Tashanna Myers, MD
Cancer-Gynecologic, Cancer

D’Amour Center for Cancer Care

3350 Main Street, Springfield MA 01199

Franklin Medical Center

164 High Street, Greenfield MA

A Phase II-R and a Phase III Trial Evaluating Both *Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma

The purpose of this study is to evaluate the effects (good and bad) of the use of radiation after completion of gemcitabine
Seth Kaufman, MD
Cancer, Cancer - Pancreatic

D’Amour Center for Cancer Care

3350 Main Street, Springfield MA 01199

A Phase III Prospective Randomized Trial Of Dose-Escalated Radiotherapy With Or Without Short-Term Androgen Deprivation Therapy For Patients With Intermediate-Risk Prostate Cancer

The purpose of this study is to compare the effects of dose-escalated radiation therapy with or without hormone therapy on your prostate cancer.
Seth Kaufman, MD
Cancer - Prostate, Cancer

D’Amour Center for Cancer Care

3350 Main Street, Springfield MA 01199

A Phase III Randomized Study of Nivolumab Plus Ipilimumab Versus Nivolumab for Previously Treated Patients with Stage IV Squamous Cell Lung Cancer and No Matching Biomarker

John McCann, MD
Cancer, Cancer - Lung

D'Amour Center for Cancer Care

3350 Main Street
Springfield, MA 01199

A Phase III Trial Evaluating The Addition Of Trastuzumab To Trimodality Treatment Of HER2-Overexpressing Esophageal Adenocarcinoma

Seth Kaufman, MD
Cancer - Esophogus, Cancer

D’Amour Center for Cancer Care

3350 Main Street, Springfield MA 01199

Page 1 of 5 | Results 1 - 10 of 46